Biofluid Based Biomarkers in Neuropsychiatric Syndromes - The Metabolic Derangements Webinar
Release: 09/12/2022 (no credit available)
Faculty
Fabricio Ferreira de Oliveira, M.D., B.B.A, M.Sc., Ph.D.
Executive Medical Director
Elysian Clinic São Paulo, Brazil
Zahinoor Ismail, M.D. FRCPC
Professor of Psychiatry, Neurology, Epidemiology and Pathology
Hotchkiss Brain Institute and O’Brien Institute for Public Health
Cumming School of Medicine, University of Calgary
George Perry, PhD
The University of Texas at San Antonio
United States
Ramit Ravona-Springer, MD
Tel Aviv University
Israel
| Funding Statement | Complimentary |
| Copyright Statement with Logo | Home Office Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 Alzheimer's Association is a not-for-profit 501(c)(3) organization. © 2022 Alzheimer’s Association®. All rights reserved.  |
| Target Audience / Intended Audience | This activity is intended to meet the educational needs of psychologists, primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia. |
| Statement of Need / Activity Purpose |
Research with biofluid biomarkers aims to establish objective associations with behavioral and cognitive changes, but depends upon anthropometric and sociodemographic variables that may affect the final results. Though neuropsychiatric syndromes may serve as proxy markers for neuropathological change, neuropsychiatric assessment must take human diversity into account. In this third webinar, we will discuss potential uses of biomarkers for neuropsychiatric diagnosis and drug response. |
| Learning Objectives |
ACTIVITY - EN 450-0622 Upon completion of this webinar you will learn:
|
| Method of Participation |
This curriculum will take approximately 60 minutes to complete. To receive maximum credit, participants are required to view the presentation in its entirety. Upon completion of the activity and evaluation form, a certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate. |
| Faculty Disclosures |
Disclosures- Faculty reports the following relationship(s) Dr. Fabricio Ferreira de Oliveira discloses that consultancies to Gerson Lehrman Group, Atheneum Partners, Guidepoint, Rain Partners, Health Advances, and Lionbridge. All of the relevant financial relationships listed for the disclosures have been mitigated. Dr. Zahinoor Ismail has no relevant financial disclosures. Dr. George Perry has disclosed consultancies to NervGen and Synaptogenix, and is a stockholder in Synaptogenix and Neurotez. All of the relevant financial relationships listed for the disclosures have been mitigated. Dr. Ramit Ravona-Springer has no relevant financial disclosures. Dr. Claire Sexton, Alzheimer’s Association staff, has no relevant financial disclosures. |
| Hardware and Software Requirements |
Hardware and Software Requirements
|